Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
申请人:Taylor Malcolm George
公开号:US20080255134A1
公开(公告)日:2008-10-16
The present invention provides compounds of formula (I) possessing inhibitory activity against β adrenergic receptors and phosphodiesterase (PDE), including type 3 phosphodiesterase (PDE-3). The present invention further provides pharmaceutical compositions comprising such compounds, methods of preparing such compounds, and methods of using such compounds for regulating calcium homeostasis, for treating a disease, disorder or condition in which disregulation of calcium homeostasis is implicated and for treating cardiovascular disease, stroke, epilepsy, an ophthalmic disorder or migraine.
本发明提供了具有抑制β肾上腺素受体和磷酸二酯酶(PDE)活性的式(I)化合物,包括3型磷酸二酯酶(PDE-3)。本发明还提供了包括此类化合物的制药组合物,制备此类化合物的方法,以及使用此类化合物调节钙离子稳态,治疗涉及钙离子稳态失调的疾病、紊乱或状况,以及治疗心血管疾病、中风、癫痫、眼科疾病或偏头痛的方法。